Myelin Pathology Disease Comparison — AD/PD/ALS/FTD/HD

Overview

Myelin — the lipid-rich electrical insulator produced by oligodendrocytes in the CNS — is essential for rapid saltatory conduction and metabolic support of axons. Myelin pathology is a common and early feature across Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Huntington’s disease (HD), though the underlying mechanisms differ substantially between diseases^{1Myelinogenesis and myelin biology — a therapeutic target in neurology2024 · Annu Rev Neurosci · DOI 10.1146/annurev-neuro-083123-031256Open reference2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}.

Oligodendrocytes are uniquely vulnerable due to high metabolic demands, iron-rich environment, and dependence on axonal signals for survival. Each disease presents a distinct pattern: tau pathology in AD affects oligodendrocyte viability; alpha-synuclein in PD disrupts myelin maintenance; TDP-43 pathology in ALS/FTD drives oligodendrocyte-specific transcriptional dysfunction; and mutant huntingtin in HD causes widespread transcriptional repression of myelin genes^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference4Oligodendrocyte pathology in frontotemporal dementia and ALS: common mechanisms and therapeutic targets2017 · Brain · DOI 10.1093/brain/awx095Open reference5Oligodendrocyte dysfunction in ALS: evidence from human postmortem tissue and experimental models2023 · Acta Neuropathol · DOI 10.1007/s00401-023-02582-6Open reference}.

Comparison Matrix

WMH = white matter hyperintensities; OPC = oligodendrocyte precursor cell; MBP = myelin basic protein; PLP = proteolipid protein; CNPase = 2’,3’-cyclic nucleotide 3’-phosphodiesterase

Myelin Biology: Oligodendrocyte Function and Vulnerability

Normal Oligodendrocyte Function

Oligodendrocytes produce myelin sheaths that wrap axons in a lipid-rich, multi-layered membrane structure. A single oligodendrocyte can myelinate up to 50 axons. Myelin functions include:

• Electrical insulation: Enables saltatory conduction, increasing conduction velocity by 50-100x

• Axonal metabolic support: Oligodendrocytes transfer lactate and pyruvate to axons via monocarboxylate transporters (MCT1/MCT4)^{6Regulation of axonal energy by oligodendrocytes2011 · Nat Neurosci · DOI 10.1038/nn.2910Open reference}

• Axonal survival signals: Neuregulin-1 and other axonal signals maintain oligodendrocyte survival

• Structural organization: Myelin organizes axonal domains including nodes of Ranvier, paranodes, and juxtaparanodes

Why Oligodendrocytes Are Vulnerable

1. High metabolic demand: Myelin synthesis requires massive amounts of lipids and proteins

2. Iron requirement: Oligodendrocytes require high iron for cytochromes; this iron becomes pro-oxidant under stress^{7Iron accumulation in oligodendrocytes and myelin breakdown in neurodegenerative disease2018 · Cell Mol Neurobiol · DOI 10.1007/s10571-018-0584-6Open reference}

3. Axonal dependence: Oligodendrocyte survival depends on axonal signals

4. Limited regenerative capacity: OPC differentiation declines with age and disease

5. Long myelin lifespan: Human myelin has a half-life of ~50-100 years, making it susceptible to cumulative damage^{1Myelinogenesis and myelin biology — a therapeutic target in neurology2024 · Annu Rev Neurosci · DOI 10.1146/annurev-neuro-083123-031256Open reference}

Disease-Specific Mechanisms

Alzheimer’s Disease: Amyloid and Tau-Mediated Myelin Breakdown

Myelin pathology is an early and widespread feature of AD, often preceding detectable amyloid or tau pathology^{8Myelin integrity in Alzheimer's disease: white matter hyperintensities and cognitive decline2019 · Neurobiol Aging · DOI 10.1016/j.neurobiolaging.2019.06.011Open reference9Myelin water imaging in Alzheimer's disease and aging2017 · Neuroimage · DOI 10.1016/j.neuroimage.2017.02.051Open reference}.

Amyloid-beta effects on oligodendrocytes:

• Aβ directly toxic to oligodendrocytes via caspase activation and mitochondrial dysfunction^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}0

• Aβ oligomers impair OPC differentiation, blocking remyelination

• APOE4 disrupts oligodendrocyte function and myelin maintenance through lipid metabolism impairment

Tau pathology in oligodendrocytes:

• 4R tau isoforms expressed in oligodendrocytes; pathological tau accumulation in AD white matter

• Oligodendrocyte tau pathology correlates with white matter integrity loss

• Tau propagation: tau seeds from neurons can enter oligodendrocytes^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}1

Myelin protein changes:

• Significant reduction in MBP and PLP in postmortem AD brains

• Myelin fragmentation visible on electron microscopy in pre-dementia stages

Evidence from imaging:

• White matter hyperintensities (WMH) present in up to 90% of AD patients^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}2

• DTI shows reduced fractional anisotropy (FA), reflecting myelin damage^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}3

Parkinson’s Disease: Alpha-Synuclein and Iron-Mediated Myelin Dysfunction

White matter changes in PD include demyelination and oligodendrocyte loss in substantia nigra and broader brain regions^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}4^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}5^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}6.

Alpha-synuclein in oligodendrocytes:

• Pathological αSyn inclusions found in oligodendrocytes in PD brains

• αSyn in oligodendrocytes disrupts MBP and PLP expression and leads to myelin breakdown

• GBA mutations exacerbate lysosomal dysfunction in oligodendrocytes

Iron accumulation:

• Substantia nigra oligodendrocytes accumulate high iron levels in PD^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}7

• Iron catalyzes Fenton reactions, generating ROS that damage myelin

• Ferritin (iron storage) elevated in PD white matter

Oligodendrocyte precursor cell dysfunction:

• OPCs in PD show reduced proliferation and differentiation capacity

• Loss of dopamine disrupts OPC maturation (dopamine D2 receptors on OPCs)

• Neurotrophic factor support (BDNF, GDNF) for OPCs is impaired

Amyotrophic Lateral Sclerosis: TDP-43-Driven Oligodendrocyte Dysfunction

Oligodendrocyte pathology is a major feature of ALS, with TDP-43 inclusions and functional impairment observed in multiple studies^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}8^{2Myelin formation and regulation of oligodendrocyte differentiation2010 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a020479Open reference}9.

TDP-43 pathology in oligodendrocytes:

• TDP-43 mislocalizes to cytoplasm in ALS oligodendrocytes

• TDP-43 regulates splicing of myelin genes — its loss disrupts alternative splicing of MBP, PLP, and other myelin transcripts^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}0

• Oligodendrocyte-specific TDP-43 knockdown in mice causes demyelination and motor neuron degeneration

Functional consequences:

• Significant oligodendrocyte loss in spinal cord white matter of ALS patients

• Myelin breakdown in corticospinal tracts

• Reduced MCT1 expression — impaired axonal metabolic support^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}1

• OPCs in ALS fail to mature into myelinating oligodendrocytes

Overlap with FTD:

• C9orf72 repeat expansions cause both ALS and FTD with overlapping oligodendrocyte pathology

• TDP-43 pathology in oligodendrocytes is a shared feature across ALS-FTD spectrum^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}2

Frontotemporal Dementia: TDP-43, Progranulin, and Tau Myelinopathy

White matter atrophy is prominent in FTD, with distinct patterns across subtypes^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}3^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}4.

FTD-TDP (most common):

• TDP-43 pathology in oligodendrocytes widespread in FTD-TDP

• Nuclear TDP-43 loss causes splicing defects in myelin genes

• Progressive white matter atrophy in frontal and temporal lobes

FTD-GRN (progranulin mutations):

• GRN regulates lysosomal function — loss causes lysosomal dysfunction in oligodendrocytes

• GRN mutation carriers show white matter hyperintensities even pre-symptomatically

FTD-tau (CBD, PSP, Pick’s disease):

• Tau pathology in oligodendrocytes is a hallmark of 4R tauopathies (CBD, PSP)^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}5

• Oligodendrocytes accumulate tau inclusions (coiled bodies) and show myelin loss

Huntington’s Disease: Mutant Huntingtin Transcriptional Repression of Myelin Genes

Huntington’s disease shows widespread white matter pathology, with demyelination beginning in pre-symptomatic gene carriers^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}6^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}7.

Mutant huntingtin effects on oligodendrocytes:

• mHTT accumulates in oligodendrocyte nuclei and acts as a transcriptional repressor

• mHTT represses myelin genes including PLP, MBP, CNPase, and transcription factors (MYRF, SOX10)

• Postmortem HD brains show reduced PLP and MBP expression in striatum and cortex^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}8

Iron and myelin in HD:

• Iron accumulates in striatum and white matter of HD patients^{3Myelin pathology in Alzheimer's disease and Parkinson's disease: a comparative postmortem study2018 · Acta Neuropathol Commun · DOI 10.1186/s40478-018-0616-zOpen reference}9

• Iron catalyzes oxidative damage to myelin lipids and proteins

Metabolic dysfunction:

• Oligodendrocytes in HD show impaired energy metabolism

• Reduced MCT1 expression — impaired axonal metabolic support^{4Oligodendrocyte pathology in frontotemporal dementia and ALS: common mechanisms and therapeutic targets2017 · Brain · DOI 10.1093/brain/awx095Open reference}0

Shared Mechanisms of Myelin Pathology

Iron Dysregulation

Iron accumulates in the aging brain and is accelerated across all five neurodegenerative diseases^{4Oligodendrocyte pathology in frontotemporal dementia and ALS: common mechanisms and therapeutic targets2017 · Brain · DOI 10.1093/brain/awx095Open reference}1:

• Mechanism: Fenton chemistry (Fe2+ + H2O2 → Fe3+ + OH•) generates hydroxyl radicals that peroxidate myelin lipids

• Pattern: Iron accumulates in myelin sheaths, oligodendrocyte soma, and white matter tracts

• Disease-specific: Highest in PD substantia nigra, HD striatum, and ALS motor cortex

Metabolic Failure

Oligodendrocytes are highly metabolically active cells^{4Oligodendrocyte pathology in frontotemporal dementia and ALS: common mechanisms and therapeutic targets2017 · Brain · DOI 10.1093/brain/awx095Open reference}2:

• Glucose hypometabolism: Reduced glucose uptake affects oligodendrocyte function

• Mitochondrial dysfunction: Multiple OXPHOS defects in oligodendrocytes across AD, PD, ALS, HD

• Lactate shuttle impairment: Reduced MCT1/MCT4 expression leads to inadequate axonal metabolic support

Neuroinflammation and OPC Dysfunction

Activated microglia and astrocytes create a hostile microenvironment:

• Pro-inflammatory cytokines: IL-1β, TNF-α, IL-6 block OPC differentiation

• Microglial phagocytosis: Microglia phagocytose myelin debris, reducing substrate for remyelination

• Astrocyte reactivity: Reactive astrocytes upregulate CSPGs that inhibit OPC migration and differentiation

Therapeutic Strategies for Myelin Repair

Biomarkers of Myelin Pathology

Mermaid Diagram: Myelin Pathology Across Diseases

flowchart TB
    subgraph Shared["Shared Myelin Pathology Mechanisms"]
        IRON["Iron Accumulation<br/>(AD/PD/ALS/FTD/HD)"]
        INFLAM["Neuroinflammation<br/>(Microglia/Astrocyte)"]
        METAB["Metabolic Failure<br/>(Mitochondria/OXPHOS)"]
        OPC["OPC Dysfunction<br/>(Reduced Differentiation)"]
    end

    subgraph AD["AD-Specific Myelin Pathology"]
        AB["Abeta Toxicity to OLs"]
        TAU_OL["Tau in Oligodendrocytes"]
        APOE4["APOE4 Myelin Dysfunction"]
    end

    subgraph PD["PD-Specific Myelin Pathology"]
        ASYN_OL["alphaSyn in Oligodendrocytes"]
        IRON_SN["Iron in SNc"]
        DOP_OPC["Dopamine-OPC Signaling Loss"]
    end

    subgraph ALS["ALS-Specific Myelin Pathology"]
        TDP43_OL["TDP-43 in OLs"]
        SPLICE["Myelin Gene Splicing Loss"]
        LACTATE["MCT1 Loss (Lactate Shuttle)"]
    end

    subgraph FTD["FTD-Specific Myelin Pathology"]
        TDP43_FTD["TDP-43 in OLs"]
        GRN_OL["Progranulin Deficiency"]
        TAU_OL_FTD["4R Tau in OLs (CBD/PSP)"]
    end

    subgraph HD["HD-Specific Myelin Pathology"]
        MHTT["mHTT Transcriptional Repression"]
        MYELIN_GENES["PLP/MBP Repression"]
        IRON_STRIATUM["Iron in Striatum"]
    end

    IRON --> OL_DEATH["Oligodendrocyte Death"]
    INFLAM --> OPC_BLOCK["OPC Differentiation Block"]
    METAB --> MYELIN_LOSS["Myelin Breakdown"]
    OPC --> REMYEL_FAIL["Remyelination Failure"]

    AB --> MYELIN_LOSS
    TAU_OL --> MYELIN_LOSS
    APOE4 --> METAB

    ASYN_OL --> MYELIN_LOSS
    IRON_SN --> IRON
    DOP_OPC --> OPC_BLOCK

    TDP43_OL --> SPLICE
    SPLICE --> MYELIN_LOSS
    LACTATE --> METAB

    TDP43_FTD --> SPLICE
    GRN_OL --> METAB
    TAU_OL_FTD --> MYELIN_LOSS

    MHTT --> MYELIN_GENES
    MYELIN_GENES --> MYELIN_LOSS
    IRON_STRIATUM --> IRON

    MYELIN_LOSS --> AXON_DEATH["Axonal Death"]
    REMYEL_FAIL --> AXON_DEATH
    OL_DEATH --> AXON_DEATH

    style IRON fill:#3a3000,stroke:#333
    style INFLAM fill:#f8bbd0,stroke:#333
    style METAB fill:#0a1929,stroke:#333
    style OPC fill:#3a3000,stroke:#333
    style AXON_DEATH fill:#3b1114,stroke:#333
    style MYELIN_LOSS fill:#3b1114,stroke:#333

Key Findings

1. Myelin pathology is universal: All five neurodegenerative diseases show significant myelin dysfunction, though primary mechanisms differ (Aβ, tau, αSyn, TDP-43, mHTT)

2. Oligodendrocytes are a primary target: TDP-43 pathology in ALS/FTD, iron accumulation in PD, transcriptional repression in HD all target oligodendrocytes directly

3. Shared mechanisms: Iron dysregulation, neuroinflammation, and metabolic failure drive myelin loss across diseases

4. Remyelination failure: OPCs are present but fail to differentiate due to inflammatory and metabolic barriers

5. Therapeutic window: Promoting remyelination or protecting existing myelin could slow disease progression across all five diseases

See Also

• Oligodendrocyte Dysfunction in Neurodegeneration

• Demyelination

• Wallerian Degeneration

• Neuroinflammation Comparison

• Iron Dyshomeostasis Comparison

• Protein Aggregation Disease Comparison

• Mitochondrial Dysfunction Comparison

• Alzheimer’s Disease

• Parkinson’s Disease

• ALS

• Frontotemporal Dementia

• Huntington’s Disease